Meeting program

15:30 - 15:45 CET Opening Ceremony

15:45 - 16:45 CET Session 1: DLBCL: Definition, diagnosis and pathogenesis

Chair: A Ivanaj (Albania)

Lecture: DLBCL: Definition, diagnosis and pathogenesis
B Chapuy (Germany)
Self-assessment case I: DLBCL on three siblings with hepatitis B through vertical transmission
A Cili (Albania)
Self-assessment case II: Approach in the diagnosis and treatment of Primary mediastinal large B-cell lymphoma, EBV positive-Case report
V Çavolli (Kosovo)

16:45 - 17:00 CET Break

17:00 - 18:15 CET Session 2: First-line treatment of DLBCL

Chair: A Cili (Albania)

Lecture: First-line treatment of DLBCL
I Aurer (Croatia)
Self-assessment case I: Primary mediastinal large B-cell lymphoma (PMBCL)
OD Preda (Romania)
Self-assessment case II: Diffuse Large B-Cell Lymphoma
T Vassilakopoulos (Greece)

15:30 - 16:30 CET Session 3: Second-line treatment of DLBCL

Chair: O Karanfilski (North Macedonia)

Lecture: Second-line treatment of DLBCL
U Vitolo (Italy)
Self-assessment case I: A case of ocular lymphoma, the challenge in diagnosis and treatment
E Calliku (Albania)
Self-assessment case II: A primary DLBCL of the cervix, a rare entity
A Perolla (Albania)

16:30 - 16:45 CET Break

16:45 - 17:45 CET Session 4: CAR-T cell therapy: What's next in the treatment of DLBCL

Chair: J Tsonis (Greece)

Lecture: CAR-T cell therapy: What's next in the treatment of DLBCL
MJ Kersten (The Netherlands)
Self-assessment case I: Complete Remission after CAR-T therapy
D Dujmović (Croatia)
Self-assessment case II: CAR-T Cell Therapy
S Ratip (Türkiye)

17:45 - 18:00 CET Closing remarks

The European Hematology Association (EHA)